GMP Fundamentals: Key Questions Answered

EU-GMP (European Union Good Manufacturing Practice) is a regulatory framework governing the manufacture of pharmaceutical products. In the context of medical cannabis, it ensures that products are consistently produced and controlled according to defined quality standards.

Compliance with EU-GMP is typically required for cannabis products to be distributed in regulated international markets, particularly within Europe.

GACP (Good Agricultural and Collection Practices) applies to cultivation and harvesting, ensuring plant material is produced under controlled and traceable conditions.

EU-GMP applies to processing and manufacturing, requiring validated systems, controlled environments, and a comprehensive quality management system.

GACP material is generally considered a prerequisite input for EU-GMP processing.

A Qualified Person (QP) is a designated individual responsible for certifying that each batch of product has been manufactured and tested in accordance with EU-GMP requirements.

QP certification is required before a product can be released for sale or distribution in many regulated markets, particularly within the European Union.

Batch release refers to the formal approval of a manufactured batch of product following review of all production, quality control, and documentation records.

This process ensures that the batch meets predefined specifications and regulatory requirements prior to distribution. In EU markets, batch release is typically performed by a Qualified Person.

A GMP-compliant facility incorporates several critical elements, including:

• Controlled environments (temperature, humidity, cleanliness) 
• Validated equipment and processes 
• Defined material and personnel flow to minimize contamination risk 
• Comprehensive documentation and batch records 
• Quality systems such as deviation management, CAPA, and change control 

These components work together to ensure product consistency, traceability, and regulatory compliance.

The European Pharmacopoeia defines standardized quality specifications for pharmaceutical substances and products, including limits for contaminants, microbial content, and active ingredient consistency.

In medical cannabis, compliance may include testing for:

• Microbiological contamination (e.g., TAMC, TYMC, pathogens) 
• Heavy metals and pesticides 
• Residual solvents (if applicable) 
• Cannabinoid content and uniformity 

EU-GMP processing ensures that products are manufactured and tested in alignment with these recognized standards.

Environmental monitoring is a program used to assess and control the cleanliness of manufacturing areas. It involves routine measurement of:

• Airborne particulates 
• Microbial contamination (e.g., surface and air sampling) 
• Temperature and humidity 

This data is used to verify that controlled environments remain within defined limits and do not pose a risk to product quality.

Process validation is the documented evidence that a manufacturing process consistently produces a product meeting its predetermined specifications and quality attributes.

It typically includes:

• Qualification of equipment and systems (IQ/OQ/PQ) 
• Validation of critical process parameters 
• Reproducibility across multiple batches 

Validation is a core requirement under EU-GMP and supports product consistency and regulatory compliance.

Data integrity refers to the accuracy, completeness, and reliability of data generated during manufacturing and quality control processes.

EU-GMP requires adherence to principles such as ALCOA+:

• Attributable 
• Legible 
• Contemporaneous 
• Original 
• Accurate
  (+ Complete, Consistent, Enduring, Available) 

Maintaining data integrity is essential for batch release, audits, and regulatory trust.

A deviation is any departure from an approved process, procedure, or specification. Under GMP, all deviations must be documented, investigated, and assessed for impact on product quality.

CAPA (Corrective and Preventive Actions) are implemented to:

• Correct the root cause of a deviation 
• Prevent recurrence 
• Improve overall process control 

Effective deviation and CAPA systems are critical components of a GMP-compliant Quality Management System.